Evidence map›Paper›PMID 32576221›Full record

ArticleDiagnostic pathology2020

A novel collision tumour of myofibroblastoma and low-grade adenosquamous carcinoma in breast.

Guang-Zhi Yang, Shang-Hua Liang, Xiao-Hong Shi

Open access · goldAbstract readCase Reports
In one paragraph

Article in Diagnostic pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Guang-Zhi YangDepartment of Pathology, Beijing Dian Medical Test Laboratory Co. Ltd, No. 9 Tianfu Street, Daxing District, 102600, Beijing, People's Republic of China. yang_gzhi@hotmail.com.
Shang-Hua LiangDepartment of Pathology, Beijing Dian Medical Test Laboratory Co. Ltd, No. 9 Tianfu Street, Daxing District, 102600, Beijing, People's Republic of China.
Xiao-Hong ShiDepartment of Pathology, Beijing Dian Medical Test Laboratory Co. Ltd, No. 9 Tianfu Street, Daxing District, 102600, Beijing, People's Republic of China.
Dian Diagnostics (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMyofibroblastoma (MFB) and low-grade adenosquamous carcinoma (LGASC) are rare tumours in the breast, respectively. However, a collision tumour of the two types has never been reported. CASE PRESENTATION: A 42-year-old female presented with a palpable mass in diameter of about 2.5 cm in the left breast. Morphologically, the lesion was predominately composed of bland spindle cells admixed with some islands of mature adipocytes and a few epithelial elements dispersing in infiltrating way which formed both tubule and solid structures. The mass showed low positive index of Ki-67. The spindle cells were strongly and diffusely positive for CD34, SMA, desmin, ER and PR. The epithelial elements were positive for CK and EMA, and negative for ER and PR completely. CK5/6 and P63 were positive in the outer-layer of the tubules and nearly all the cells of the solid nests.

conclusionsA collision tumour of MFB and LGASC in breast is extremely rare and either component is supposed to be not overlooked. Excision and close follow-up are advised.

Indexed as

AdultBreast NeoplasmsCarcinoma, AdenosquamousFemaleHumansNeoplasms, Complex and MixedNeoplasms, Muscle TissueBreastCollision tumourLow-grade adenosquamous carcinomaMyofibroblastoma

Identifiers

PMID32576221
PMCPMC7313209
OpenAlexW3036315001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.